Confidently diagnose respiratory disease during telehealth consultations
ResAppDx is Australia's only TGA approved, clinically validated remote respiratory cough test. Developed by ResApp Health, ResAppDx analyses cough sounds using clinically validated algorithms to provide indications for lower respiratory tract disease, pneumonia, asthma/reactive airway disease exacerbations, COPD exacerbations, bronchiolitis and croup.
Remote respiratory symptom testing
Benefits for your practice
An improved telehealth assessment using ResAppDx may:
Reduce unnecessary clinic referrals and lengthy clinical testing
Facilitate earlier and better targeted treatment
Reduce the spread of infectious disease with less physical contact
Improve patient convenience and experience
How ResAppDx works
We have partnered with these leading telehealth platforms
Please contact us if you'd like to use ResAppDx on another telehealth platform or in your clinic.
Frequently asked questions
Contact us to learn more
If you have any questions or would like to find out how you can use ResAppDx in your clinic, please complete the form below.
Only indicated for use on patients aged 29 days and older. The result of the test should not be used as a sole diagnosis. The result should be used as part of an overall clinical assessment of the patient. Please refer to the Instructions for Use for information on interpreting the results and the clinical performance of ResAppDx.